23andMe Investor Presentation Deck

Unique to 23and Me: FDA-Authorized Pharmacogenetics Reports 3 reports and 3 medication insights that look at genetic variants that influence how a person responds or processes certain medications (FDA-cleared) SLC01B1 Drug Transport CYP2C19 Drug Metabolism DPYD Drug Metabolism Statin-induced myopathy Clopidogrel, citalopram response Fluoropyrimidine toxicity Copyright © 2023 23and Me, Inc. 23andMe 21

View entire presentation